Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Zinc of Ireland NL ( (AU:ZMI) ) is now available.
Zinc of Ireland NL has outlined a substantial proposed issue of securities, including up to 550 million new fully paid ordinary shares and large tranches of performance rights and options for directors, advisers, and officers. The issue, scheduled for early June 2026 subject to ASX processes, is structured as a placement or similar transaction and is designed to incentivise key personnel while significantly expanding the company’s capital base, with potential dilution and governance implications for existing shareholders.
The proposal includes separate A and B classes of performance rights and options, totalling hundreds of millions of new incentive instruments alongside the ordinary shares. This mix of equity and equity-linked awards underscores the company’s reliance on market-based compensation to align management and adviser interests with long-term performance, while signalling an intention to advance its corporate and project objectives through enhanced access to capital markets.
The most recent analyst rating on (AU:ZMI) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Zinc of Ireland NL stock, see the AU:ZMI Stock Forecast page.
More about Zinc of Ireland NL
Zinc of Ireland NL is an ASX-listed resources company focused on mineral exploration and development, with its primary interests likely centred on base metals such as zinc. The company raises capital and issues equity-linked instruments to fund exploration, development activities, and corporate operations in the mining sector.
YTD Price Performance: 80.0%
Average Trading Volume: 676,304
Technical Sentiment Signal: Hold
Current Market Cap: A$10.48M
For a thorough assessment of ZMI stock, go to TipRanks’ Stock Analysis page.

